Analyst Upgrades: Box, PlasmaTech, and Rite Aid

Analysts upwardly revised their ratings and price targets on Box Inc (NYSE:BOX), Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), and Rite Aid Corporation (NYSE:RAD)

Jun 11, 2015 at 9:23 AM
facebook twitter linkedin

Analysts are weighing in today on cloud concern Box Inc (NYSE:BOX), drugmaker Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), and pharmacy chain Rite Aid Corporation (NYSE:RAD). Here's a quick roundup of today's bullish brokerage notes on BOX, PTBI, and RAD.

  • BOX is exploding ahead of the open, as the company reported stronger-than-expected first-quarter numbers and raised its full-year forecast, after adding 2,000-plus subscribers during the quarter. Canaccord Genuity has since raised its price target to $21 from $20, and the shares are 12.9% higher in pre-market action. After settling at $17.79 yesterday, Box Inc is now set to open above $20 -- reaching its highest level since late March -- and short sellers are likely sweating. Nearly 10% of the stock's float is sold short, representing close to 12 days of buying power, at its normal trading pace. Analysts, too, have skeptical outlooks. Every single brokerage firm with coverage on BOX says it's a "hold."

  • PTBI is positioned 12.3% higher in electronic trading, thanks to Roth Capital, which started the stock with a "buy" rating and $16 price target. The shares are accustomed to huge jumps, as they've more than doubled since early May. Plasmatech Biopharmaceuticals Inc was last seen at $7.07, and even with these recent gains, it's still far removed from its annual high of $17.50, touched exactly one year ago. Roth Capital expects a return to double-digit levels -- and it's not the only one. PTBI's average 12-month price target comes in at $15.

  • During the past few months, RAD has been coming on strong, nearly doubling since its annual low of $4.42 in mid-October to close at $8.64 yesterday. The shares aren't slowing down yet. They're set to open 2.8% higher, after Credit Suisse reinstated coverage with an "outperform" rating. More bullish analyst attention may be on the way for Rite Aid Corporation, as it's nearing its multi-year high of $9.07 from early April. Interestingly, more and more traders have been shorting the stock, with short interest increasing over 12% during the most recent two-week reporting period. If RAD continues to rally and these bears make a quick exit, it could provide more fuel for its fire.

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!



Special Offers from Schaeffer's Trading Partners